Fresh analysis reveals that individuals who come off popular weight-loss injections like Mounjaro or Wegovy may regain shed pounds much more quickly than those who end traditional lifestyle programs.
Published data in a prominent health publication shows that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"Individuals using these treatments need to be aware of the risk of rapid rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.
This pace of recovery suggests a reversion to original weight in about one and a half years.
Analyzing Approaches
The study, which examined 37 of studies involving over 9,000 of patients, compared the results of GLP-1 agonists with older methods.
The team point out that individuals who lose weight through diet and exercise typically experience a more gradual weight regain—around 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Experts suggest the mechanism of the injections explains the accelerated rebound.
These medications mimic a natural hormone called GLP-1, which controls appetite.
"Long-term administration of the hormone levels far above than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication results in appetite is uncontrolled, making overeating much more probable."
A Lifelong Condition?
The NHS suggest the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, due to the high risk of weight regain, the therapy is often ongoing.
This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the long-term character of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
People who have come off the medication report a sudden return of cravings.
"It was like a switch that goes on and I was suddenly extremely hungry," said one woman.
This challenge is exacerbated if patients have not established lasting lifestyle or habit changes during therapy.
Significant Interest
Figures suggest that a significant number of people in the UK have used these injections in the past year, with demand continuing to grow.
- Adoption is higher among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers stress that while the jabs are potent agents for weight loss, they are not a standalone solution and long-term success hinges on combined lifestyle support.
